Results 231 to 240 of about 8,268,208 (290)

Impact of Cadmium on Prostate-Specific Antigen and Endothelial Markers: A Risk for Prostatic Damage. [PDF]

Toxics
İritaş SB, Gözükara MG, Tutkun L, Özkan Vardar D, Büyükşekerci M, Abusoğlu G, Deniz S, Türksoy VA, Tutkun E.   +8 more
europepmc   +1 more source

Aptamer–Based Targeted Protein Degradation: Mechanistic Principles, Delivery Strategies, and Translational Opportunities

Medicinal Research Reviews, EarlyView.
ABSTRACT Targeted elimination of pathogenic proteins remains a fundamental challenge in therapeutic intervention, particularly for proteins considered “undruggable” by conventional inhibition‐based approaches. Aptamer–based targeted protein degradation (TPD) has emerged as a versatile strategy that leverages the high specificity, structural ...
Ambrin Malik, Suyeon Son, Jaesung Lee, Ki Soo Park   +3 more
wiley   +1 more source

Postmortem Serum Prostate-Specific Antigen as a Potential Marker for Prostatic Disease: A Forensic Exploratory Study. [PDF]

Cureus
Matsumoto S, Takasu S.
europepmc   +1 more source

Proteomic Analysis of Mixed Cell Membrane Extracts From Triple‐Negative Breast Cancer Cell Lines Revealed Broad Metabolic Reprogramming Associated With Tumor Progression

PROTEOMICS, EarlyView.
ABSTRACT Triple‐negative breast cancer (TNBC) represents the most aggressive subtype with limited therapeutic options and the poorest clinical outcomes. Using high‐resolution nUPLC‐QTOF‐MS/MS, we performed comprehensive proteomic profiling of TNBC cell lines representing disease progression stages: HCC‐1937 (stage IIB), HCC‐1599 (stage IIIA), and MDA ...
Claudia Sissely Chaviano‐Montes de Oca, Violeta Larios‐Serrato, María Luisa Labra‐Barrios, Emmanuel Ríos‐Castro, Carlos Alberto Castañón‐Sánchez, Rodolfo Moreno‐Castillo, Erika Beatriz Ángeles‐Morales, Juan Pedro Luna‐Arias   +7 more
wiley   +1 more source

Effects of non-surgical periodontal therapy on prostate-specific antigen levels and recurrent urinary tract infections: a randomized controlled clinical study. [PDF]

Sci Rep
Castro DLE, de Urbina Comerón PO, Parra-García S, Quispe-López N, Galletti C, Lorenzo-Gómez MF, Flores-Fraile J.   +6 more
europepmc   +1 more source

Effect of apalutamide dosage on the incidence of cutaneous adverse events and prostate-specific antigen reduction in patients with prostate cancer. [PDF]

Oncol Lett
Matsuyama T, Kimura M, Go M, Yamada S, Nishimura M, Murase H, Matsuyama R, Usami E.   +7 more
europepmc   +1 more source

Superior cancer detection with transperineal biopsy in patients with an elevated prostate-specific antigen level and a PI-RADS score of 3-4: A retrospective cohort study. [PDF]

Oncol Lett
Zhang J, Zheng H.
europepmc   +1 more source

Improved prostate cancer prediction by combining Prostate-Specific Antigen (PSA) test results with Genetic Risk Scores (GRS/PRS)

Lu J, Chen G, Merriel SWD, Weedon MN, Murray A, Bailey SE, Green HD.   +6 more
europepmc   +1 more source

From prostate-specific antigen to precision: The future of prostate cancer diagnosis with artificial intelligence, biomarkers, and imaging. [PDF]

Curr Urol
Flôres Soares da Silva HM, Gómez Rivas J, Mata Déniz P, Marugan MJ, González-Santander C, Fernández Montarroso L, Galante I, Moreno Sierra J.   +7 more
europepmc   +1 more source

Multicenter Study on Integrating Prostate Magnetic Resonance Imaging with Prostate-Specific Antigen Density for Risk-Adapted Biopsy Strategy in a South Korean Cohort. [PDF]

Urol Res Pract
Lee SJ, Shin DH, Kim HY.
europepmc   +1 more source